Ensysce Biosciences (ENSC) Other Gross PP&E Adjustments (2020 - 2024)
Ensysce Biosciences (ENSC) has disclosed Other Gross PP&E Adjustments for 5 consecutive years, with -$729318.0 as the latest value for Q4 2024.
- On a quarterly basis, Other Gross PP&E Adjustments rose 2.29% to -$729318.0 in Q4 2024 year-over-year; TTM through Sep 2025 was -$729318.0, a 2.29% increase, with the full-year FY2024 number at -$729318.0, up 2.29% from a year prior.
- Other Gross PP&E Adjustments was -$729318.0 for Q4 2024 at Ensysce Biosciences, up from -$746444.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$9415.0 in Q2 2021 to a low of -$1.8 million in Q4 2020.
- A 5-year average of -$899301.8 and a median of -$831059.5 in 2021 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 49.74% in 2021, then decreased 28.12% in 2022.
- Ensysce Biosciences' Other Gross PP&E Adjustments stood at -$1.8 million in 2020, then soared by 49.74% to -$915675.0 in 2021, then fell by 28.12% to -$1.2 million in 2022, then skyrocketed by 36.37% to -$746444.0 in 2023, then increased by 2.29% to -$729318.0 in 2024.
- Per Business Quant, the three most recent readings for ENSC's Other Gross PP&E Adjustments are -$729318.0 (Q4 2024), -$746444.0 (Q4 2023), and -$1.2 million (Q4 2022).